Back to results
US 11,896,586 B2Granted
Apixaban formulations
AssigneesBristol-Myers Squibb Company, Pfizer Inc.
InventorsSherif Ibrahim Farag Badawy, Timothy D. Stevens, Daniel Kuntz, Brett Waybrant
Life of this patent
Estimating the term…
Abstract
Apixaban pharmaceutical formulation is provided. Also provided is a use of the apixaban formulation in treatment of a thromboembolic disorder.
Claims45
A treated core comprising:
- a core substrate;
- and
- apixaban and a carrier on the core substrate,
- wherein the treated core comprises from about 0.001% w/w to about 0.20% w/w apixaban, and
- wherein the apixaban and the carrier are in a layer formed on a surface of the core substrate.
2 more elements
A treated core comprising:
- a core substrate;
- and
- apixaban and a carrier on the core substrate,
- wherein the treated core comprises from about 0.001% w/w to about 0.20% w/w apixaban,
- wherein the apixaban and the carrier are in a layer formed on a surface of the core substrate, and
- wherein the apixaban and the carrier are applied to the surface of the core substrate by a spray-layered dispersion process carried out with a concentration of apixaban in a solvent below a solubility limit.
3 more elements
Dependencies are inferred from the claim text.